Figure 1.
Management of particular miRNA molecules (miR-15a-5p, miR-126-3p, miR-142-5p, miR-21-5p and miR-150-5p) in groups with Graves’ disease (GD), with Hashimoto’s thyroiditis (HT) and with nodular goiter and in control group.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.